Trial

TBTC Study 30: A Phase I/II Pilot Study for Evaluation of Low Dose, Once Daily, Linezolid Plus Optimized Background Therapy (OBT) Versus Placebo Plus OBT for the Treatment of Multi-drug Resistant Tube

Study Director
Start Date
2 / 2009
Trial Phase
Trial Status
submitted for publication
Current Enrollment
23
Target Enrollment
45
Overview
Compound Associations
Linezolid